168 related articles for article (PubMed ID: 23531850)
1. Adrenocortical carcinoma: a comprehensive immunohistochemical study of 40 cases.
Weissferdt A; Phan A; Suster S; Moran CA
Appl Immunohistochem Mol Morphol; 2014 Jan; 22(1):24-30. PubMed ID: 23531850
[TBL] [Abstract][Full Text] [Related]
2. The role of calretinin, inhibin, melan-A, BCL-2, and C-kit in differentiating adrenal cortical and medullary tumors: an immunohistochemical study.
Zhang PJ; Genega EM; Tomaszewski JE; Pasha TL; LiVolsi VA
Mod Pathol; 2003 Jun; 16(6):591-7. PubMed ID: 12808065
[TBL] [Abstract][Full Text] [Related]
3. Myxoid adrenocortical carcinoma: a clinicopathologic and immunohistochemical study of 7 cases, including 1 case with lipomatous metaplasia.
Weissferdt A; Phan A; Suster S; Moran CA
Am J Clin Pathol; 2013 Jun; 139(6):780-6. PubMed ID: 23690121
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical distinction of metastases of renal cell carcinoma to the adrenal from primary adrenal nodules, including oncocytic tumor.
Li H; Hes O; MacLennan GT; Eastwood DC; Iczkowski KA
Virchows Arch; 2015 May; 466(5):581-8. PubMed ID: 25690138
[TBL] [Abstract][Full Text] [Related]
5. Anti-alpha-inhibin: marker of choice for the consistent distinction between adrenocortical carcinoma and renal cell carcinoma in fine-needle aspiration.
Fetsch PA; Powers CN; Zakowski MF; Abati A
Cancer; 1999 Jun; 87(3):168-72. PubMed ID: 10385449
[TBL] [Abstract][Full Text] [Related]
6. Comparison of immunohistochemical markers in the differential diagnosis of adrenocortical tumors: immunohistochemical analysis of adrenocortical tumors.
Zhang H; Bu H; Chen H; Wei B; Liu W; Guo J; Li F; Liao D; Tang Y; Zhang Z
Appl Immunohistochem Mol Morphol; 2008 Jan; 16(1):32-9. PubMed ID: 18091323
[TBL] [Abstract][Full Text] [Related]
7. Histopathological study of adrenocortical carcinoma with special reference to the Weiss system and TNM staging and the role of immunohistochemistry to differentiate it from renal cell carcinoma.
Mondal SK; Dasgupta S; Jain P; Mandal PK; Sinha SK
J Cancer Res Ther; 2013; 9(3):436-41. PubMed ID: 24125979
[TBL] [Abstract][Full Text] [Related]
8. A tissue microarray-based comparative analysis of novel and traditional immunohistochemical markers in the distinction between adrenal cortical lesions and pheochromocytoma.
Sangoi AR; McKenney JK
Am J Surg Pathol; 2010 Mar; 34(3):423-32. PubMed ID: 20154585
[TBL] [Abstract][Full Text] [Related]
9. [Diagnostic value of A103 and inhibin-alpha in adrenocortical tumors: an immunohistochemical study using tissue microarray techniques].
Zhang HY; Wang XJ; Liu WP; Jiang LL; Li GD; Guo J; Zhang YH
Zhonghua Bing Li Xue Za Zhi; 2004 Jun; 33(3):203-7. PubMed ID: 15256108
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical distinction of primary adrenal cortical lesions from metastatic clear cell renal cell carcinoma: a study of 248 cases.
Sangoi AR; Fujiwara M; West RB; Montgomery KD; Bonventre JV; Higgins JP; Rouse RV; Gokden N; McKenney JK
Am J Surg Pathol; 2011 May; 35(5):678-86. PubMed ID: 21490444
[TBL] [Abstract][Full Text] [Related]
11. Calretinin and inhibin are useful in separating adrenocortical neoplasms from pheochromocytomas.
Jorda M; De MB; Nadji M
Appl Immunohistochem Mol Morphol; 2002 Mar; 10(1):67-70. PubMed ID: 11893039
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of immunohistochemical markers in adrenocortical carcinoma.
Zlatibor L; Paunovic I; Zivaljevic V; Dundjerovic D; Tatic S; Djukic V
Acta Chir Belg; 2020 Feb; 120(1):23-29. PubMed ID: 30499377
[No Abstract] [Full Text] [Related]
13. Primary rhabdoid adrenocortical carcinoma: a clinicopathological and immunohistochemical study of three cases.
Weissferdt A; Phan A; Suster S; Moran CA
Histopathology; 2013 Apr; 62(5):771-7. PubMed ID: 23445527
[TBL] [Abstract][Full Text] [Related]
14. Comparative analysis of alternative and traditional immunohistochemical markers for the distinction of ovarian sertoli cell tumor from endometrioid tumors and carcinoid tumor: A study of 160 cases.
Zhao C; Bratthauer GL; Barner R; Vang R
Am J Surg Pathol; 2007 Feb; 31(2):255-66. PubMed ID: 17255771
[TBL] [Abstract][Full Text] [Related]
15. Oncocytic Adreno Cortical Tumors: Pathological Features of 16 Cases and Review of the Literature.
Ertan Y; Argon A; Özdemir M; Yürekli BPS; Dökümcü Z; Makay Ö
J Environ Pathol Toxicol Oncol; 2017; 36(3):237-244. PubMed ID: 29283337
[TBL] [Abstract][Full Text] [Related]
16. Adrenocortical carcinoma. An immunohistochemical comparison with renal cell carcinoma.
Wick MR; Cherwitz DL; McGlennen RC; Dehner LP
Am J Pathol; 1986 Feb; 122(2):343-52. PubMed ID: 2418689
[TBL] [Abstract][Full Text] [Related]
17. Adrenocortical Cancer: A 20-Year Experience of a Single Referral Center in Prognosis and Outcomes.
Parianos C; Kyriakopoulos G; Kostakis ID; Nasiri-Ansari N; Aggeli C; Dimitriadi A; Angelousi A; Papavassiliou AG; Kaltsas GA; Zografos G; Kassi E
Horm Metab Res; 2021 Nov; 53(11):709-716. PubMed ID: 34740271
[TBL] [Abstract][Full Text] [Related]
18. Histologic and immunohistochemical classification of 41 bovine adrenal gland neoplasms.
Grossi AB; Leifsson PS; Jensen HE; Vainer B; Iburg T
Vet Pathol; 2013 May; 50(3):534-42. PubMed ID: 23242804
[TBL] [Abstract][Full Text] [Related]
19. Overlapping expression of immunohistochemical markers and synaptophysin mRNA in pheochromocytomas and adrenocortical carcinomas. Implications for the differential diagnosis of adrenal gland tumors.
Komminoth P; Roth J; Schröder S; Saremaslani P; Heitz PU
Lab Invest; 1995 Apr; 72(4):424-31. PubMed ID: 7723281
[TBL] [Abstract][Full Text] [Related]
20. A "tumour trifecta:" myelolipomata arising within an adrenocortical adenoma ipsilateral to a synchronous clear cell renal cell carcinoma.
Mahe E; El-Shinnawy I
Malays J Pathol; 2010 Dec; 32(2):123-8. PubMed ID: 21329184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
